^○Moses Lorenzo Akyeh^1,2, Masatomo Morita³, Quynh Anh Pham Hong⁴, Hien Tran Thi⁴, Linh Tuyet Ngoc Pham⁴, , Nguyen Dong Tu Tu⁴, Taichiro Takemura Takemura⁴, Hiroyuki Terashima², Hirataka Hiyoshi², Toshio Kodama² (1.Graduate School of Biomedical Sciences, Nagasaki University, 2.Dept of Bacteriology, Inst Trop Med, Nagasaki Univ, Nagasaki, Japan, 3.Dept of Bacteriology I, Nat Inst Infect Dis, Tokyo, Japan, 4.Vietnam Research Station, Inst Trop Med, Nagasaki Univ, Hanoi, Vietnam)

Anne Dickinson¹, Abbas Ishaq¹, Matthew Freer¹, ^○Anzai Takayuki³, Toshihide Hayashi⁴ (1.Alcyomics Ltd, 2.Newcastle University, Newcastle upon Tyne UK, 3.Showa University School of Medicine, 4.Japan SLC, Inc. Biotechnical Center)

Brandon Malone¹, Ioannis Vardaxis¹, Boris Simovski¹, Simen Tennoe¹, Marius Gheorghe¹, Agnieszka Gromadka¹, Kousuke Onoue⁴, Yuki Tanaka⁴, Sebastian Kapell¹, Pierre Machart³, Roman Volchenkov³, Onoguchi Kazuhide¹, Richard Stratford⁴, ^○Trevor Clancy^1,2 (1.NEC OncoImmunity, Norway, 2.Institute of Tropical Medicine, Nagasaki University, Japan, 3.NEC Research Laboratories Europe, Germany, 4.NEC Corporation, Japan)

^○Rashmi R Dash^1,2, Negishi Hideo^3,4, Michelle SJ Lee^1,4, Ken. J. Ishii^3,4, Shiroh Iwanaga⁵, Cevayir Coban^1,2,4 (1.Division of Malaria Immunology, Institute of Medical Science (IMSUT), University of Tokyo, 2.Graduate School of Frontier Science, University of Tokyo, 3.Division of Vaccine Science, IMSUT, University of Tokyo, 4.International Vaccine Design Center, IMSUT, University of Tokyo, 5.Department of Protozoology, RIMD, Osaka University)

^○Toshiki Eri¹, Herve Blanc², Thomas Bigot³, Malgorzata E. Mnich¹, Pedro Goncalves¹, Evangelia Eleftheriou¹, Lionel Frangeul², Darragh Duffy⁴, Jean-Laurent Casanova^5,6,7,8, Maria-Carla Saleh², James P. Di Santo¹ (1.Innate Immunity Unit, Inserm U1223, Institut Pasteur, Paris, France, 2.Viruses and RNA Interference Unit, Institut Pasteur, CNRS, Paris, France, 3.Bioinformatic and Biostatistic Hub - Computational Biology Department, Institut Pasteur, Universite de Paris, Paris, France, 4.Translational Immunology Lab, Institut Pasteur, Paris, France, 5.Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France, 6.University of Paris, Imagine Institute, Paris, France, 7.St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA, 8.Howard Hughes Medical Institute, New York, NY, USA)

^○Shigeru Fujita¹, Yusuke Kosugi¹, Izumi Kimura¹, Kenzo Tokunaga², Jumpei Ito¹, Kei Sato¹ (1.Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, 2.Department of Pathology, National Institute of Infectious Diseases)

^○Marius Gheorghe¹, Brandon Malone¹, Richard Stratford¹, Trevor Clancy^1,2 (1.NEC OncoImmunity , Norway, 2.Institute of Tropical Medicine, Nagasaki University, Japan)

^○Su Myat Han^1,2, Robert Alexis², Endo Akira^1,2, Baguelin Marc^2,7, Saito Nobu^4,5, Suzuki Motoi^1,6, Masuda Shingo^1,3, Kanda Satoshi³, Komori Kazuhiri³, Yasaka Takahiro³, Ariyoshi Koya^4,5 (1.School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan, 2.Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK, 3.Department of Internal Medicine, Kamigoto Hospital, Kamigoto, Japan, 4.Department of Microbiology, Faculty of Medicine, Oita University, Yufu, Japan, 5.Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan, 6.Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan, 7.MRC Centre for Global Infectious Disease Analysis and the Abdul Latif Jameel Institute for Disease, London, UK)

^○Shuhei Higuchi^1,2, Yafei Liu^1,2, Shimizu Jun³, Ono Chikako^4,5, Itoh Yumi⁶, Okamoto Toru⁶, Matsuura Yoshiharu^4,5, Shioda Tatsuo⁷, Arase Hisashi^1,2 (1.Department of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Japan, 2.Laboratory of Immunochemistry, WPI Immunology Frontier Research Center, Osaka University, Japan, 3.MiCAN Technologies, Inc., Japan, 4.Laboratory of Virus Control, Center for Infectious Disease Education and Research, Osaka University, Japan, 5.Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Japan, 6.Department of Microbiology, Juntendo University School of Medicine, Japan, 7.Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University, Japan)

^○Shangfan Hu^1,2,3, Yoko Fujita-Fujiharu^1,2,3, Yukihiko Sugita^1,3,4, Lisa Wendt⁵, Yukiko Muramoto^1,2,3, Masahiro Nakano^1,2,3, Thomas Hoenen⁵, Takeshi Noda^1,2,3 (1.Laboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, 2.Laboratory of Ultrastructural Virology, Graduate School of Biostudies, Kyoto University, 3.CREST, Japan Science and Technology Agency, 4.Hakubi Center for Advanced Research, Kyoto University, 5.Laboratory for Integrative Cell and Infection Biology, Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut)

Yarob Ibraheem¹, Ganchimeg Bayarsaikhan¹, Maria Lourdes Macalinao², Kazumi Kimura¹, Katsuyuki Yui², ^○Shin-Ichi Inoue¹ (1.Division of Immunology, Graduate School of Biomedical Sciences, Nagasaki University, Japan, 2.School of Tropical Medicine and Global Health, Nagasaki University.)

^○Jumpei Ito¹, Spyros Lytras², Kei Sato¹ (1.Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 2.Medical Research Council-University of Glasgow Centre for Virus Research, Glasgow, UK)

^○Mariko Kamioka^1,2, Julia Matsuo-Dapaah¹, Michelle Sue Jann Lee¹, Cevayir Coban¹ (1.Division of Malaria Immunology, The Institute of Medical Science, The University of Tokyo, Japan, 2.Research Fellow of the Japan Society for the Promotion of Science (JSPS), Japan)

^○Takehiro Kanda^1,2, Santos Pauline³, Hoper Dirk³, Beer Martin³, Rubbenstroth Dennis³, Tomonaga Keizo^1,2,4 (1.Laboratory of RNA viruses, Institute for Life and Medical Sciences, Kyoto University, Japan, 2.Department of Molecular Virology, Graduate School of Medicine, Kyoto University, Japan, 3.Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Germany, 4.Department of Mammalian Regulatory Network, Graduate School of Biostudies, Kyoto University, Japan)

Akihisa Kato, Iwasaki Ryoji, Takeshima Kousuke, Maruzuru Yuhei, Koyanagi Naoto, ^○Kawaguchi Yasushi (Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Japan)

Seong Eun Bae, Minhyuk Yoon, Young-Shin Park, Man Ki Song, ^○Jae-Ouk Kim (Molecular Immunology, Science Unit, International Vaccine Institute, Seoul, Korea)

^○Kirakarn Kirativanich¹, Chatchadaporn Thamnurak¹, Chantida Praditpol¹, Brian A Vesely¹, Norman C Waters¹, John H Adams², Nonlawat Boonyalai¹ (1.Department of Bacterial and Parasitic Diseases, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand, 2.Department of Global Health, College of Public Health, University of South Florida, Tampa, FL33620, USA)

^○Chanikarn Kodchakorn, Nattaya Ruamsap, Rawiwan Imerbsin, Anchalee Tungtaeng, Phakorn Wilaisri, Alongkorn Hanrujirakomjorn, Siriphan Gonwong, Nonlawat Boonyalai, Samandra T Demons, Brian A Vesely, Pattaraporn Vanachayangkul (Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand)

^○Kieran D Lamb (MRC-University of Glasgow Centre for Virus Research)

^○HAOKUN LI, Hikaru Namba, Hirohito Ogawa, Tomoyuki Honda (Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama University)

^○Yuki Masuo^1,2, Hiroyuki Yoshitomi¹, Yoshitaka Honda^1,3, Hajime Morita¹, Shuhe Ma^1,3, Takao Hashiguchi^2,4, Akihiko Sugimoto⁵, Sachiko Minamiguchi⁵, Hironori Haga⁵, Tatsuya Kamitori⁶, Hideki Yokoi⁷, Takamoto Hirota⁸, Kinta Hatakeyama⁹, Yoshihiko Ikeda⁹, Keiko Ohta-Ogo⁹, Masanori Matsumoto¹⁰, Tomoya Hayashi¹¹, Ken J. Ishii¹¹, Fumihiro Fujiki¹², Tadaki Suzuki¹³, Shun Iida¹³, Harutaka Katano¹³, Hideki Ueno^1,2,3 (1.Department of Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 2.Kyoto University Immunomonitoring Center, Kyoto University, Kyoto, Japan, 3.ASHBi Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto, Japan, 4.Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan, 5.Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan, 6.Department of Pediatrics, Kyoto University Hospital, Kyoto, Japan, 7.Department of Nephrology, Kyoto University Hospital, Kyoto, Japan, 8.Department of Cardiology, Osaka Saiseikai Noe Hospital, Osaka, Japan, 9.Department of Pathology, National Cerebral and Cardiovascular Center Hospital, Suita, Japan, 10.Department of Hematology, Nara Medical University, Kashihara, Japan, 11.Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 12.Department of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Suita, Japan, 13.Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan)

^○Julia Matsuo-Dapaah^1,2, Michelle S. J. Lee^1,3, Manabu Ozawa⁴, Masahiro Yamamoto⁵, Ken J. Ishii^3,6, Cevayir Coban^1,2,3 (1.Division of Malaria Immunology, Institute of Medical Science, University of Tokyo, Japan, 2.Graduate School of Medicine, University of Tokyo, Japan, 3.International Vaccine Design Center, Institute of Medical Science, University of Tokyo, Japan, 4.Laboratory of Reproductive Systems Biology, Institute of Medical Science, University of Tokyo, Japan, 5.Department of Immunoparasitology, WPI Immunology Frontier Research Center, Osaka University, Japan, 6.Division of Vaccine Science, Institute of Medical Science, University of Tokyo, Japan)

^○Shohei Minami¹, Nouda Ryotaro¹, Sonoda Shizuka¹, Onishi Megumi¹, Kotaki Tomohiro¹, Kanai Yuta¹, Kobayashi Takeshi^1,2,3 (1.Department of Virology, Research Institute for Microbial Diseases, Osaka University, Japan, 2.Center for Infectious Disease Education and Research, Osaka University, Japan, 3.Center for Advanced Modalities and DDS, Osaka University, Japan)

^○Rayhane Nchioua¹, Caterina Prelli-Bozzo¹, Dorota Kmiec¹, Fabian Zech¹, Sabrina Noettger¹, Annika Schundner², Manfred Frick², Steffen Just³, Konstantin M. J. Sparrer¹, Frank Kirchhoff¹ (1.Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany, 2.Institute of General Physiology, Ulm University, 3.Molecular Cardiology, Department of Internal Medicine II, Ulm University, Ulm, Germany)

^○MOEKA NOBE, Yuhei Maruzuru, Kosuke Takeshima, Naoto Koyanagi, Akihisa Kato, Yasushi Kawaguchi (Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan)

^○Kazuma Okada^1,2, Yuki Hirai¹, Yumi Ushikai¹, Atsushi Kaida¹ (1.Microbiology Section, Division of Microbiology, Osaka Institute of Public Health, 2.Laboratory of Viral Control, Center for Infectious Disease Education and Research, Research Institute for Microbial Diseases, Osaka University)

^○Ryo Ozuru, Ishii Kazunari, Fujiki Shotaro, Hiromatsu Kenji (Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University)

^○Micheal T Pillay^1,2, Noboru Minakawa^1,3, Jayanthi V Ratnam⁴, Swadhin K Behera⁴, Nyakallo Kgalane⁵ (1.Institute of Tropical Medicine, Nagasaki University, 2.Graduate School of Biomedical Sciences, Nagasaki University, 3.Department of Vector Ecology and Environment, Institute of Tropical Medicine, Nagasaki University, 4.Application Laboratory, Japan Agency for Marine-Earth Science and Technology (JAMSTEC), 5.Limpopo Department of Health, Malaria Control)

^○David G Priest¹, Janyerkye Tulyeu^1,2, Jonas N Sondergaard^1,2, Yuki Togami³, Yumi Mitsuyama⁴, Shuhei Sakakibara⁵, Takeshi Ebihara³, Hisatake Matsumoto³, Hiroshi Ogura³, James B Wing^1,2 (1.Laboratory of Human Single Cell Immunology, iFReC, Osaka University, 2.Human Single Cell Immunology Team, CiDER, Osaka University, 3.Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, 4.Division of Trauma and Surgical Critical Care, Osaka General Medical Center, 5.Laboratory of Immune Regulation, iFReC, Osaka University)

^○Dianita S Saputri¹, Hendra S Ismanto¹, Dendi K Nugraha¹, Zichang Xu², Yasuhiko Horiguchi^1,3, Shuhei Sakakibara^2,4, Daron M Standley^1,2,3 (1.Research Institute for Microbial Diseases, Osaka University, Japan, 2.Immunology Frontier Research Center, Osaka University, Japan, 3.Center for Infectious Disease Education and Research, Osaka University, Japan, 4.Graduate School of Medical Safety Management, Jikei University of Health Care Sciences, Japan)

^○Takayuki Shibahara¹, Temizoz Burcu², Ishii Ken J.² (1.Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, 2.Division of Vaccine Science The Institute of Medical Science, The University of Tokyo)

^○Atsushi Shimoyama¹, Yamaura Haruki^1,2, Hosomi Koji², Saika Azusa², Di Lorenzo Flaviana³, Matamoros-Recio Alejandra⁴, Martin Santamaria Sonsoles^1,4, Molinaro Antonio^1,3, Kunisawa Jun^1,2, Fukase Koichi¹ (1.Graduate School of Science, Osaka University, 2.National Institutes of Biomedical Innovation, Health and Nutrition, 3.Department of Chemical Sciences, University of Naples Federico II, 4.Spanish National Research Council)

^○Tsuyoshi Suzuki¹, Yamamoto Natsuo¹, Yamamoto Hideki², Iseki Ken¹ (1.Graduate school of Medicine, Fukushima Medical University, Japan, 2.School of Health Sciences, Niigata University, Japan)

^○Ryosuke Takasaki¹, Takuro Matsuoka¹, Norihito Arichi¹, Sho Yamasaki^2,3, Hiroaki Ohno¹, Shinsuke Inuki¹ (1.Graduate School of Pharmaceutical Sciences, Kyoto Univ., Japan, 2.Research Institute for Microbial Diseases, Osaka Univ., Japan, 3.Immunology Frontier Research Center (IFReC), Osaka Univ., Japan)

^○Sarunporn Tandhavanant^1,2, Hiroyuki Terashima¹, Dhira Saraswati Anggramukti³, Hirotaka Hiyoshi¹, Narisara Chantratita², Tetsuya Iida³, Shigeaki Matsuda³, Toshio Kodama¹ (1.Department of Bacteriology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan, 852-8523, 2.Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, 10400, 3.Department of Bacteriology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan, 565-0871)

^○BURCU TEMIZOZ^1,2, TAKAYUKI SHIBAHARA^2,3, KOU HIOKI¹, MICHELLE SUE JANN LEE⁵, NAZ SURUCU⁹, ERDAL SAG¹⁰, MASAHIRO YAMAMOTO⁴, CEVAYIR COBAN^5,11, MAYDA GURSEL¹², SEZA OZEN¹⁰, ETSUSHI KURODA¹³, ATSUSHI KUMANOGOH^3,6,7,8, KEN J ISHII^1,2,11 (1.Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 2.Laboratory of Mockup Vaccine, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan, 3.Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan, 4.Department of Immunoparasitology, Division of Infectious Disease, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan, 5.Division of Malaria Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 6.Department of Immunopathology, WPI, Immunology Frontier Research Center (iFReC), Osaka University, Suita, Osaka, Japan, 7.Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Suita, Osaka, Japan, 8.Center for Infectious Diseases for Education and Research (CiDER), Osaka University, Suita, Osaka, Japan, 9.Department of Biological Sciences, Middle East Technical University (METU), Ankara, Turkey, 10.Department of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey, 11.International Vaccine Design Center (VDesC), The Institute of Medical Science (IMSUT), The University of Tokyo, Tokyo, Japan, 12.Izmir Biomedicine and Genome Center, Izmir, Turkey, 13.Department of Immunology, School of medicine, Hyogo Medical University, Nishinomiya, Hyogo, Japan)

^○Asuka J Tobuse¹, Kouji Kobiyama^1,2, Jun Tsuchida¹, Teppei Hara¹, Masamitsu Asaka³, Daichi Utsumi³, Tomoya Hayashi¹, Burcu Temizoz¹, Hideo Negishi¹, Yasuhiro Yasutomi³, Ken J Ishii^1,2 (1.Division of Vaccine Science, The Institute of Medical Science, The University of Tokyo, 2.International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, 3.Laboratory of Immunoregulation and Vaccine Research, Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition)

^○Tomoya Tsubo¹, Naganori Nao^1,2,3, Katendi Changula⁴, Hayato Harima⁵, Yongjin Qiu⁶, Akina Mori-Kajihara¹, Yoshiki Eto¹, Michihito Sasaki¹, Edgar Simulundu^4,7, Daniel Mwizabi⁸, Bernard M Hangombe^4,9, Hirofumi Sawa^1,2,3,4, Ayato Takada^1,2,4, Masahiro Kajihara¹ (1.International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan, 2.One Health Research Center, Hokkaido University, Sapporo, Japan, 3.Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Japan, 4.School of Veterinary Medicine, the University of Zambia, Lusaka, Zambia, 5.Laboratory of Veterinary Public Health, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan, 6.Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan, 7.Macha Research Trust, Choma, Zambia, 8.Department of National Parks and Wildlife, the Ministry of Tourism and Arts, Lusaka, Zambia, 9.Africa Center of Excellence for Infectious Diseases of Humans and Animals, University of Zambia, Lusaka, Zambia)

^○Kentaro Uemura^1,2,3,4,5, Haruaki Nobori², Akihiko Sato^2,3,6, Shinsuke Toba^2,3, Shinji Kusakabe^2,3, Michihito Sasaki³, Yasuko Orba³, Yoshiharu Matsuura^4,5, Hirofumi Sawa^3,6, Akira Matsuda⁷, Katsumi Maenaka^1,6,7,8 (1.Faculty of Pharmaceutical Sciences, Hokkaido University, Japan, 2.Drug Discovery and Disease Research Laboratory, Shionogi & Co., Ltd., Japan, 3.International Institute for Zoonosis Control, Hokkaido University, Japan, 4.Center for Infectious Disease Education and Research, Osaka University, Japan, 5.Research Institute for Microbial Diseases, Osaka University, Japan, 6.Institute for Vaccine Research and Development, Hokkaido University, Japan, 7.Center for Research and Education on Drug Discovery, Hokkaido University, Japan, 8.Global Station for Biosurfaces and Drug Discovery, Hokkaido University, Japan)

^○Farzaneh Valanezhad¹, Jalal Alshaweesh¹, Bijay Kumar Jha², Abhay R Satoskar³, Bradford S McGwire² (1.Institute of Tropical Medicine, Nagasaki University, Japan, 2.Division of Infectious Disease, Department of Medicine, The Ohio State University, Columbus, Ohio, USA., 3.Department of Pathology, The Ohio State University, Columbus, Ohio, USA)

^○Shinya Watanabe, Chijioke A Nsofor, Kanate Thitiananpakorn, Xin-Ee Tan, Yoshifumi Aiba, Kazuhiko Miyanga, Srivani Veeranarayanan, Longzhu Cui (Division of Bacteriology, Department of Infection and Immunity, Jichi Medical University, Japan)

^○Daichi Yamasoba^1,2, Izumi Kimura¹, Naganori Nao³, Yusuke Kosugi¹, Keiya Uriu¹, Jumpei Ito¹, Shinya Tanaka⁴, Keita Matsuno⁵, Hirofumi Sawa⁶, Takasuke Fukuhara⁷, Kei Sato¹ (1.Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Japan, 2.Faculty of medicine, Kobe University, Japan, 3.Division of International Research Promotion, International Institute for Zoonosis Control, Hokkaido University, Japan, 4.Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Japan, 5.Division of Risk Analysis and Management, International Institute for Zoonosis Control, Hokkaido University, Japan, 6.Division of Biological Response Analysis, Institute for Vaccine Research and Development, Hokkaido University, Japan, 7.Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University, Japan)

^○Yuya Yoshioka^1,2, Ken J. Ishii² (1.Laboratory for Bio-Drug Discovery, Shionogi & Co., Ltd., Osaka, Japan, 2.Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan)

^○Priya Priydarshni, Vahab Ali (Department of Biochemistry, ICMR-RMRIMS, AgamKuan, Patna-07, India)

^○Ruofan PENG, Herbert Santos, Tomoyoshi Nozaki (Department of International Health, Graduate School of Medicine, The University of Tokyo, Japan)

^○Reina Miyajima¹, Takahiro Yamada^1,2, Genshiro Sunagawa³, Takeshi Sakurai⁴, Koji Hase¹ (1.Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Science, Keio University, 2.Department of Immunobiology, Yale School of Medicine, 3.Laboratory for Hibernation Biology, RIKEN Center for Biosystems Dynamics Research, 4.Faculty of Medicine, University of Tsukuba)